There isn't a cure for neurofibromatosis type 1 (NF1), but symptoms can be managed. Generally, the sooner someone is under the care of a specialist trained in treating NF1, the better the outcome.
Monitoring
If your child has NF1, often yearly age-appropriate checkups are recommended to:
- Check your child's skin for new neurofibromas or changes in existing ones.
- Check for signs of high blood pressure.
- Check your child's growth and development. This includes measuring height, weight and head circumference to compare to growth charts for children who have NF1.
- Look for signs of early puberty.
- Look for any skeletal changes.
- Check your child's learning development and progress in school.
- Get a complete eye exam.
Contact your healthcare team right away if you notice any changes in symptoms between visits. Many complications of NF1 can be treated effectively if therapy starts early.
Medicine
Selumetinib (Koselugo) is a treatment approved by the U.S. Food and Drug Administration for plexiform neurofibroma in children. The medicine can shrink the size of a tumor. Clinical trials of similar medicines are currently being done for children and adults.
Surgery and other procedures
Surgery to remove tumors may be needed to treat serious symptoms or complications of NF1. Symptoms can be relieved by removing all or part of tumors that are compressing nearby tissue or damaging organs.
Cancer treatment
Cancers related to NF1 are treated with standard cancer therapies, such as surgery, chemotherapy and radiation therapy. Early diagnosis and treatment are the most important factors for a good outcome.
Potential future treatments
Researchers are testing gene therapies for neurofibromatosis type 1 (NF1). Potential new treatments could include replacing the NF1 gene to restore the function of neurofibromin.